Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PZG
|
|||
| Drug Name |
Tetra-hydro-quinoline derivative 4
|
|||
| Synonyms |
PMID26924192-Compound-85
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
FORMA THERAPEUTICS INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H27N3O3
|
|||
| Canonical SMILES |
CCCOC1=C(C=CC2=C1CCC(N2C(=O)C)C)C3=CN(N=C3)CCO
|
|||
| InChI |
1S/C20H27N3O3/c1-4-11-26-20-17(16-12-21-22(13-16)9-10-24)7-8-19-18(20)6-5-14(2)23(19)15(3)25/h7-8,12-14,24H,4-6,9-11H2,1-3H3/t14-/m0/s1
|
|||
| InChIKey |
LCUMODKDHNQTRE-AWEZNQCLSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.